key: cord-1017948-qiphsrjz
authors: Oliviero, Giovanni; Ruggiero, Luigi; D’Antonio, Elvira; Gagliardi, Mario; Nunziata, Rubino; Di Sarno, Alessandro; Abbatiello, Carmelina; Di Feo, Elvira; De Vivo, Simona; Santonicola, Antonella; Iovino, Paola
title: Impact of COVID‐19 lockdown on symptoms in patients with functional gastrointestinal disorders: Relationship with anxiety and perceived stress
date: 2021-02-07
journal: Neurogastroenterol Motil
DOI: 10.1111/nmo.14092
sha: d7485ae0a66132352599ff7da1db8e6f7f65e681
doc_id: 1017948
cord_uid: qiphsrjz

BACKGROUND: Psychological stress and anxiety, such those generated by forced quarantine, affect gastrointestinal symptoms course in patients with functional gastrointestinal disorders. Thus, our aim was to assess, in a cohort of patients regularly followed up in a devoted outpatient clinic of Southern Italy, the association between their gastrointestinal symptoms changes, stress, and anxiety reported during the Italian lockdown. METHODS: We recruited patients from the outpatient clinic of the University of Salerno, devoted to functional gastrointestinal disorders, selecting only patients for whom an evaluation was available in the last 6 months before the lockdown. Gastrointestinal symptoms were evaluated at each visit through standardized questionnaire and pooled in a database. On 45th days from the beginning of the lockdown, patients were re‐assessed by phone with the same questionnaire. Anxiety and stress levels were assessed through a self‐administered online questionnaire based on Generalized Anxiety Disorder 7 test and Perceived Stress Scale 10 test. KEY RESULTS: The intensity‐frequency scores of several upper gastrointestinal symptoms improved (Wilcoxon test <0.05). Higher anxiety levels had a higher risk of worsening chest pain (OR 1.3 [1.1–1.7]), waterbrash (OR 1.3 [1.0–1.7]), epigastric burning (OR 1.3 [1.0–1.6]), and abdominal pain (OR 1.6 [1.0–2.3]). When compared to the interval preceding the outbreak, half of the patients declared their symptoms remained unchanged, 13.6% worsened, and 36.4% improved. CONCLUSIONS AND INFERENCES: During the COVID‐19 quarantine, there was an improvement of the majority of upper gastrointestinal symptoms in our patients, and anxiety seems an important risk of worsening few of them.

The outbreak of COVID-19, which started in the Chinese province of Hubei over the last months of 2019, has quickly spread throughout the world, forcing affected nations to adopt restrictive measures and forced quarantine, which has, therefore, resulted in a great limitation on individual freedom. In Italy, the restrictive measures due to the widespread outbreak of COVID- 19 axis, Sympathetic-Adrenal-Medullary (SAMs) system, and regulatory neuroendocrine systems, finally causing diseases onset and deterioration of the clinical course. 3, 4 In this context, Functional Gastrointestinal Disorders (FGIDs) fit perfectly. FGIDs are syndromes based on upper and/or lower gastrointestinal (GI) symptoms that cluster together and are diagnosed by Rome IV criteria, only after excluding organic or structural underlying disorders. 5 The presence and reciprocal interactions among social, psychological, and biological factors are necessary conditions for the FGID development and maintenance. 5 Prospective studies have demonstrated that among environmental stressors that have been linked to FGID, the experience of stressful life events is associated with symptom exacerbation and frequent healthcare seeking among adults with irritable bowel syndrome (IBS). 6 Mood disorders such as depression and anxiety occur in most of FGID patients, conditioning GI symptoms onset and maintenance through their associated heightened autonomic arousal (in response to stress) or at the level of the brain, which can interfere with GI sensitivity and motor function. [7] [8] [9] [10] [11] Previous studies showed how stress conditions, anxiety and depression could increase pain levels in IBS patients, and gastric discomfort in patients with functional dyspepsia (FD), as the result of the alteration of visceral pain stimuli brain processing and of colonic and gastric motility patterns. 10, [12] [13] [14] [15] The neurophysiological basis of the possible link between FGID and psychological processes and psychiatric comorbidity has been studying extensively, specifically, the critical role of bidirectional signaling mechanisms between the GI tract and the central nervous system. 10 To the best of our knowledge, there are no studies investigating the association between psychological distress secondary to COVID-19 outbreak and FGID symptoms.

Thus, our aim was to assess in a cohort of patients with FGID regularly followed up in a devoted outpatient clinic of the South of Italy the association between their symptom changes and stress and anxiety reported during the Italian national lockdown.

For this study, patients from the outpatient clinic of the University of Salerno, devoted to FGID, were recruited. Sixty-nine patients with Functional Heartburn (FH), FD and/or IBS and its subgroups according to Rome IV criteria, 5,16-18 examined over the last 6 months before the COVID-19 outbreak, were selected from a prospectively maintained database. Age, gender, weight, height, body mass index (BMI) as well as a number of upper and lower GI symptoms that are routinely collected at each visit using a standardized questionnaire were pooled in a database (T0). On 45 th days from the beginning of Italian lockdown, these patients were contacted by a phone call and re-assessed by gastroenterologists with expertise in FGID for their upper and lower GI symptoms using the same standardized questionnaire (T1). Furthermore, patients who successfully answered to the standardized questionnaire were invited to fill in an online selfadministered internet-based questionnaires immediately sent by a message with a link via email, WhatsApp, or Facebook.

A previously published standardized questionnaire dealing with the presence, the frequency from 0 to 3 (0 = absent, 1 = 2 d/wk; 2 = 3-5 d/wk; and 3 = 6 or 7 d/wk) and the intensity from 0 to 3 (0 = absent; 1 = not very bothersome, not interfering with daily activities; 2 = bothersome, but not interfering with daily activities; and 3 = interfering with daily activities), of a number of upper and lower GI symptoms is routinely used in our outpatient clinic. 19, 20 Upper GI symptoms such as dysphagia for solids, dysphagia for liquids, regurgitation, heartburn, non-cardiac chest pain, ENT (ear, nose, throat) symptoms, cough, odynophagia, waterbrash, belching, • Higher anxiety levels had a higher risk of worsening chest pain, waterbrash, epigastric burning and abdominal pain.

anal blockage, usage of digital and/or manual maneuvers to facilitate evacuation, lower abdominal bloating, visible lower abdominal distension, flatulence, urgency, incontinence were collected. For each symptom, a frequency-intensity score from 0 up to a maximum of 6 was obtained. Stool consistency was recorded as numerical values using the Bristol Stool Form Chart Adjectival scale for stool consistency (BSFS). 21 Daily measurement of the number of bowel movements was summarized weekly. 22

Two self-administered, internet-based structured questionnaires on Google platform were sent to measure anxiety and stress. The opening page of the survey provided information about the scope and purpose of the study and contained mandatory patient consent. Firstly, they

were asked to answer the following question online: "Compared to the interval preceding the COVID-19 outbreak, how would you score your symptoms?" (1 = extremely worsened; 2 = worsened; 3 = unchanged; 4 = improved; 5 = extremely improved).

Disorder (GAD-7) test, a 7-item questionnaire that asked patients how often, during the last two weeks, each symptom had been bothering them. The following option answers: "not at all," "several days," "more than half the days," and "nearly every day", scored as 0, 1, 2, and 3. 23 For its accuracy, GAD-7 is an approved "gold standard" tool, based on an internationally recognized diagnostic system. 24 A score of 8 or more on the GAD-7 is a cutoff for cases of GAD.

Stress levels were evaluated by the Perceived Stress Scale 10 (PSS-10) test. The PSS evaluates the degree to which an individual perceived life as unpredictable, uncontrollable, and overloading in the previous month. The PSS consists of 10-items that were rated on a five-point response scale (0 = never, 1 = almost never, 2 = sometimes, 3 = fairly often, 4 = very often). All item scores must be combined to produce a total score in the range 0-40. A high score indicates a high degree of perceived stress, and no cutoffs were predefined. [25] [26] [27] 

The primary outcome was the impact of perceived stress and anxiety on upper and lower GI symptom changes before and during late COVID-19 outbreak.

Secondary outcome was the response to the question, "Compared to the interval preceding the COVID-19 outbreak, how would you score your symptoms?" (1 = extremely worsened; 2 = worsened; 3 = unchanged; 4 = improved; 5 = extremely improved) and its association with the level of anxiety measured by GAD-7 and stress by PSS-10 in all FGID patients.

Frequencies, median and Interquartile range (IQR) or means and standard deviations for discrete or continuous variables were computed, respectively. When appropriate, a χ 2 test to compare categorical data and Analysis of Variance (ANOVA) to compare continuous variables were used. The intensity-frequency score of each GI symptom before and at 45 days after the Italian lockdown (T0 vs T1) was compared by the Wilcoxon's test for paired data. Intensityfrequency scores changes (T1 vs T0) were calculated for each GI symptom and recoded as improved/neutral or worsened.

Logistic regression models were built to assess the relationship between each GI symptom improved/neutral or worsened as de- 

Demographic characteristics are shown in Table 1 . Sixty-nine patients agreed to answer the standardized questionnaire to evaluate FGID symptoms and were enrolled. Forty-four (63.7%) patients filled in the online questionnaires to assess their anxiety and stress levels. There were no significant differences in age, sex, BMI, FGID diagnosis, and any symptom evaluated before lockdown between patients who filled in the online questionnaire and patients who did not ( Table 2) .

None reported symptoms possibly due to SARS-CoV-2 infection and none in their family members or cohabitants were diagnosed with COVID-19. During late COVID-19 lockdown, the intensityfrequency scores of regurgitation, heartburn, odynophagia, belching, nausea, epigastric fullness, and early satiety significantly improved compared to the interval before the COVID-19 outbreak.

(Wilcoxon test <0.05 in all cases). The remaining GI symptoms did not reach a statistical significance (Table 3 ). Figure 1 shows the box plots of upper and lower GI symptom. Performing the logistic regression analysis higher anxiety level was the risk factor of worsening of chest pain, waterbrash, epigastric burning, and abdominal pain (Table 4) .

When compared to the interval preceding the COVID-19 outbreak, half of the patients declared that their FGIDs symptoms remained unchanged, 13.6% worsened or extremely worsened, whereas the remaining 36.4% improved or extremely improved. 

In the present study, we investigated symptoms changes in FGID In this context, it is well known that brain and gut are closely related 5 and anxiety disorders occur in 30%-50% of FGIDs' patients. In a previous retrospective study, conducted on 4966 healthcare seekers, mood or anxiety disorders might be found more than 3 years before the FGIDs' onset. 30 Previous studies underlined how psychological stress and anxiety could modulate FGIDs and related symptoms severity, often in a negative way. Anxiety levels were shown to correlate negatively with gastric sensitivity in a FD subgroup considered hypersensitive to gastric distension. 13 Another study that took into account both acute and chronic anxiety associated with impaired accommodation in FD confirmed previous pathophysiological studies in healthy volunteers showing an impairment of gastric accommodation during experimentally induced acute anxiety. 13 In a recent study, focused on the relationship between co-morbid FD and IBS patients and the severity of psychological symptoms, an independent association between anxiety levels and severity of GI symptoms was found after lactulose nutrient-challenge test, in particular for symptoms as gas, bloating, nausea, and digestive comfort.

These results confirmed that psychological states are important factors associated with FD symptom severity. 31 In this study, the improvement, as at times modest, of intensity-frequency scores of several of GI symptoms during lockdown reached the statistical significance. However, caution is required in the clinical interpretation of these results, especially when considering that these might be in apparent contrast with previous studies. This difference, indeed, might be explained by

Chest pain 1. However, in our patients' higher anxiety levels rather than stress perception increased the risk of worsening chest pain, waterbrash, epigastric burning, and abdominal pain. These results are in key with previous findings that showed how anxiety is able to alter visceral pain stimuli brain processing and visceral motility patterns causing the symptoms worsening. 10 

In conclusion, an improvement of the majority of upper GI symptoms compared to before the COVID-19 forced quarantine was found in our FGID patients. Although multiple psychological risk factors might be linked to GI symptoms onset and maintenance in FGID patients, in this study that investigated the impact of perceived stress and anxiety on GI symptoms, only anxiety was associated with a significant risk of worsening chest pain, waterbrash, epigastric burning, and abdominal pain.

The authors have no conflicts of interest to disclose. This article is not submitted or under consideration by any other publication.

Giovanni Oliviero involved in study concept and design; analysis, interpretation and acquisition of data; drafting of the manuscript; 

SARS control and psychological effects of quarantine

Mental health status of people isolated due to Middle East Respiratory Syndrome

A stage model of stress and disease

Psychological stress and disease

Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV

Biopsychosocial aspects of functional gastrointestinal disorders

Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options

Anxiety and depression as markers of multiplicity of sites of functional gastrointestinal disorders: a gender issue

State and trait anxiety and depression in patients affected by gastrointestinal diseases: psychometric evaluation of 1641 patients referred to an internal medicine outpatient setting

Is there a causal link between psychological disorders and functional gastrointestinal disorders?

Irritable bowel syndrome in childhood: visceral hypersensitivity and psychosocial aspects

Affective disturbances modulate the neural processing of visceral pain stimuli in irritable bowel syndrome: an fMRI study

The role of psychosocial factors and psychiatric disorders in functional dyspepsia

Chronic pain in irritable bowel syndrome and other comorbid pain conditions

The sympathetic nervous system modulates perception and reflex responses to gut distention in humans

Functional esophageal disorders

Gastroduodenal disorders

A randomised clinical trial (RCT) of a symbiotic mixture in patients with irritable bowel syndrome (IBS): effects on symptoms, colonic transit and quality of life

Anhedonia in irritable bowel syndrome and in inflammatory bowel diseases and its relationship with abdominal pain

Defecation frequency and timing, and stool form in the general population: a prospective study

New onset of constipation during long-term physical inactivity: a proof-of-concept study on the immobility-induced bowel changes

A brief measure for assessing generalized anxiety disorder: the GAD-7

Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis

The construct validity of the Perceived Stress Scale

Perceived stress and bruxism in university students

Bruxism and health related quality of life in southern Italy's prison inmates

A Nationwide Survey of Psychological Distress among Italian People during the COVID-19 Pandemic: Immediate Psychological Responses and Associated Factors

Affective temperament, attachment style, and the psychological impact of the COVID-19 outbreak: an early report on the Italian general population

Mood and anxiety disorders precede development of functional gastrointestinal disorders in patients but not in the population

Functional dyspepsia and severity of psychologic symptoms associate with postprandial symptoms in patients with irritable bowel syndrome

Attention and distraction: effects on gut perception

Psychological consequences of COVID-19 pandemic in Italian MS patients: signs of resilience

Resilience is decreased in irritable bowel syndrome and associated with symptoms and cortisol response

Lockdown, quarantine measures, and social distancing: Associations with depression, anxiety and distress at the beginning of the COVID-19 pandemic among adults from Germany